Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBSA0103 vs Hyruan Plus in Knee Osteoarthritis
NCT01510535Phase 3Completed
- Sponsor
- LG Chem
- Start
- Dec 2011
- Primary completion
- Mar 2012
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Synovian in knee osteoarthritis (OA) (2 arms), sponsored by LG Chem. Primary endpoint: Weight-bearing pain evaluated by 100mm VAS. Started Dec 2011; status: completed.
02
Drugs
Synovian
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01510535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510535.